BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Pharmaconomics//FDA Catalyst Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
BEGIN:VEVENT
UID:pharmaconomics-8@pharmaconomics
DTSTAMP:20260707T004904Z
DTSTART;VALUE=DATE:20260927
DTEND;VALUE=DATE:20260928
SUMMARY:PRAX PDUFA — relutrigine
DESCRIPTION:The FDA's approval decision on relutrigine for SCN2A/SCN8A-DEE and Broad DEEs is due Sep 27\, 2026. A green light opens the market\; a complete response letter (CRL) usually sinks the stock.\n\nPrimary source: https://www.sec.gov/Archives/edgar/data/1689548/000168954826000028/praxisye2025pr.htm\n\nTrack it: https://www.pharmaconomics.com/e/8
URL:https://www.pharmaconomics.com/e/8
TRANSP:TRANSPARENT
BEGIN:VALARM
TRIGGER:-P1D
ACTION:DISPLAY
DESCRIPTION:PRAX catalyst tomorrow
END:VALARM
END:VEVENT
END:VCALENDAR